Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Allen

Showing results (211-220 of 249) with videos related to

Pageof 25
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Schizophrenia Research|June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthoodAlice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
Archives of General Psychiatry|January 4, 2012
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processingSagnik Bhattacharyya, José Alexandre Crippa, Paul Allen, et al.
Schizophrenia Bulletin|December 14, 2022
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical OutcomeEmily J Hird, Noriyuki Ohmuro, Paul Allen, et al.
Human Brain Mapping|September 17, 2011
Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging studyRenata Smieskova, Paul Allen, Andor Simon, et al.
Science Advances|December 5, 2019
Mechanisms of nuclear content loading to exosomesAkira Yokoi, Alejandro Villar-Prados, Paul Allen Oliphint, et al.
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Pageof 25

Showing results (211-220 of 249) with videos related to

Sort By:
Pageof 25
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Schizophrenia Research|June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthoodAlice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
Archives of General Psychiatry|January 4, 2012
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processingSagnik Bhattacharyya, José Alexandre Crippa, Paul Allen, et al.
Schizophrenia Bulletin|December 14, 2022
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical OutcomeEmily J Hird, Noriyuki Ohmuro, Paul Allen, et al.
Human Brain Mapping|September 17, 2011
Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging studyRenata Smieskova, Paul Allen, Andor Simon, et al.
Science Advances|December 5, 2019
Mechanisms of nuclear content loading to exosomesAkira Yokoi, Alejandro Villar-Prados, Paul Allen Oliphint, et al.
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Pageof 25